Scorpion Therapeutics Funding & Investors
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
scorpiontx.comTotal Amount Raised: $270,000,000
Scorpion Therapeutics Funding Rounds
Series B
$162,000,000
Series B Investors
Boxer CapitalEcoR1 CapitalVida VenturesAbingworthWoodline PartnersAtlas VentureWellington ManagementLogos CapitalInvusHenderson Global InvestorsOmega FundsNextech InvestOrbiMedCasdin CapitalSurveyor CapitalSeries A
$108,000,000
Series A Investors
Atlas VentureOmega FundsVida VenturesAbingworthPartners HealthCare InnovationMass General Brigham Ventures
Funding info provided by Diffbot.